Cargando…

Alginate microencapsulation of an attenuated O-antigen mutant of Francisella tularensis LVS as a model for a vaccine delivery vehicle

Francisella tularensis is the etiologic agent of tularemia and a Tier I Select Agent. Subspecies tularensis (Type A) is the most virulent of the four subspecies and inhalation of as few as 10 cells can cause severe disease in humans. Due to its niche as a facultative intracellular pathogen, a succes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freudenberger Catanzaro, Kelly C., Lahmers, Kevin K., Allen, Irving C., Inzana, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8916679/ https://www.ncbi.nlm.nih.gov/pubmed/35275912 http://dx.doi.org/10.1371/journal.pone.0259807

Ejemplares similares

Formation of the Francisella tularensis Biofilm is Affected by Cell Surface Glycosylation, Growth Medium, and a Glucan Exopolysaccharide
por: Champion, Anna E., et al.
Publicado: (2019)

The capBCA Locus is Required for Intracellular Growth of Francisella tularensis LVS
por: Su, Jingliang, et al.
Publicado: (2011)

The role of MglA for adaptation to oxidative stress of Francisella tularensis LVS
por: Honn, Marie, et al.
Publicado: (2012)

Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection
por: Mohapatra, Saroj K, et al.
Publicado: (2010)

Evolution of Antibiotic Resistance in Surrogates of Francisella tularensis (LVS and Francisella novicida): Effects on Biofilm Formation and Fitness
por: Biot, Fabrice V., et al.
Publicado: (2020)

The Francisella tularensis LVS ΔpdpC mutant exhibits a unique phenotype during intracellular infection
por: Lindgren, Marie, et al.
Publicado: (2013)

Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate
por: Kim, Eun-Ju, et al.
Publicado: (2008)

Immune lymphocytes halt replication of Francisella tularensis LVS within the cytoplasm of infected macrophages
por: Bradford, Mary Katherine, et al.
Publicado: (2020)

Francisella tularensis LVS Surface and Membrane Proteins as Targets of Effective Post-Exposure Immunization for Tularemia
por: Chandler, Jeffrey C., et al.
Publicado: (2014)

A Mucosal Subunit Vaccine Protects against Lethal Respiratory Infection with Francisella tularensis LVS
por: Ashtekar, Amit R., et al.
Publicado: (2012)

Lack of OxyR and KatG Results in Extreme Susceptibility of Francisella tularensis LVS to Oxidative Stress and Marked Attenuation In vivo
por: Honn, Marie, et al.
Publicado: (2017)

Immunoproteomics Analysis of the Murine Antibody Response to Vaccination with an Improved Francisella tularensis Live Vaccine Strain (LVS)
por: Twine, Susan M., et al.
Publicado: (2010)

IKKβ in Myeloid Cells Controls the Host Response to Lethal and Sublethal Francisella tularensis LVS Infection
por: Samaniego, Sylvia, et al.
Publicado: (2013)

IL-12p40 is essential but not sufficient for Francisella tularensis LVS clearance in chronically infected mice
por: Mittereder, Lara R., et al.
Publicado: (2023)

Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS
por: Chen, Fei, et al.
Publicado: (2017)

Multiple T Cell Subsets Control Francisella tularensis LVS Intracellular Growth Without Stimulation Through Macrophage Interferon γ Receptors
por: Cowley, Siobhán C., et al.
Publicado: (2003)

Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections
por: Robinson, Cory M, et al.
Publicado: (2015)

Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis
por: Apicella, Michael A., et al.
Publicado: (2010)

IL-23 p19 Knockout Mice Exhibit Minimal Defects in Responses to Primary and Secondary Infection with Francisella tularensis LVS
por: Kurtz, Sherry L., et al.
Publicado: (2014)

Atg5-Deficient Mice Infected with Francisella tularensis LVS Demonstrate Increased Survival and Less Severe Pathology in Internal Organs
por: Kelava, Ina, et al.
Publicado: (2020)

PdpC, a secreted effector protein of the type six secretion system, is required for erythrocyte invasion by Francisella tularensis LVS
por: Cantlay, Stuart, et al.
Publicado: (2022)

Photonic Biosensor Assays to Detect and Distinguish Subspecies of Francisella tularensis
por: Cooper, Kristie L., et al.
Publicado: (2011)

Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge
por: McCormick, Alison A., et al.
Publicado: (2018)

Glycosylation of a Capsule-Like Complex (CLC) by Francisella novicida Is Required for Virulence and Partial Protective Immunity in Mice
por: Freudenberger Catanzaro, Kelly C., et al.
Publicado: (2017)

Corrigendum: Glycosylation of a Capsule-Like Complex (CLC) by Francisella novicida Is Required for Virulence and Partial Protective Immunity in Mice
por: Catanzaro, Kelly C. Freudenberger, et al.
Publicado: (2019)

The Reduced Genome of the Francisella tularensis Live Vaccine Strain (LVS) Encodes Two Iron Acquisition Systems Essential for Optimal Growth and Virulence
por: Pérez, Natalie Marie, et al.
Publicado: (2014)

Characterization of Inner and Outer Membrane Proteins from Francisella tularensis Strains LVS and Schu S4 and Identification of Potential Subunit Vaccine Candidates
por: Post, Deborah M. B., et al.
Publicado: (2017)

Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity
por: Kurtz, Sherry L., et al.
Publicado: (2021)

A ΔclpB Mutant of Francisella tularensis Subspecies holarctica Strain, FSC200, Is a More Effective Live Vaccine than F. tularensis LVS in a Mouse Respiratory Challenge Model of Tularemia
por: Golovliov, Igor, et al.
Publicado: (2013)

Comparative review of Francisella tularensis and Francisella novicida
por: Kingry, Luke C., et al.
Publicado: (2014)

Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates
por: Santiago, Araceli E., et al.
Publicado: (2015)

A human macrophage – hepatocyte co-culture model for comparative studies of infection and replication of Francisella tularensis LVS strain and subspecies holarctica and mediasiatica
por: Rennert, Knut, et al.
Publicado: (2016)

Francisella tularensis, Portugal
por: Lopes de Carvalho, Isabel, et al.
Publicado: (2007)

Etymologia: Francisella tularensis
por: Männikkö, Nancy
Publicado: (2011)

Metapopulation structure for perpetuation of Francisella tularensis tularensis
por: Goethert, Heidi K, et al.
Publicado: (2009)

Use of a Capture-Based Pathogen Transcript Enrichment Strategy for RNA-Seq Analysis of the Francisella Tularensis LVS Transcriptome during Infection of Murine Macrophages
por: Bent, Zachary W., et al.
Publicado: (2013)

Francisella tularensis in Rodents, China
por: Zhang, Fang, et al.
Publicado: (2006)

Further Characterization of the Capsule-Like Complex (CLC) Produced by Francisella tularensis Subspecies tularensis: Protective Efficacy and Similarity to Outer Membrane Vesicles
por: Champion, Anna E., et al.
Publicado: (2018)

Models Derived from In Vitro Analyses of Spleen, Liver, and Lung Leukocyte Functions Predict Vaccine Efficacy against the Francisella tularensis Live Vaccine Strain (LVS)
por: De Pascalis, Roberto, et al.
Publicado: (2014)

Regulation of Francisella Tularensis Virulence
por: Dai, Shipan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ub05nlcr2qpipqao7s62vemhjd